The impact of schistosoma japonicum infection and treatment on ultrasound-detectable morbidity: A five- year cohort study in Southwest China

PLoS Neglected Tropical Diseases

Volumn 4, Issue 5, 2010, Pages

  Carlton, Elizabeth J ^a   Hsiang, Michelle ^b   Zhang, Yi ^c   Johnson, Sarah ^a,d   Hubbard, Alan ^a   Spear, Robert C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SICHUAN CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^d NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRAZIQUANTEL;

ADULT; ARTICLE; CHILD; CHINA; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CONTROL; DRUG RESPONSE; ECHOGRAPHY; FECES ANALYSIS; FEMALE; HUMAN; LIVER EXAMINATION; LIVER FIBROSIS; LIVER PARENCHYMA; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRESCHOOL CHILD; SCHISTOSOMIASIS JAPONICA; SEX DIFFERENCE; SPLEEN EXAMINATION; SPLENOMEGALY; TREATMENT OUTCOME; ADOLESCENT; ANIMAL; COHORT ANALYSIS; DRUG MONITORING; FECES; FIBROSIS; FOLLOW UP; HOSPITALIZATION; ISOLATION AND PURIFICATION; LIVER; MIDDLE AGED; PARASITOLOGY; PATHOLOGY; SCHISTOSOMA JAPONICUM; SPLEEN;

ADOLESCENT; ADULT; ANIMALS; CHILD; CHILD, PRESCHOOL; CHINA; COHORT STUDIES; DRUG MONITORING; FECES; FEMALE; FIBROSIS; FOLLOW-UP STUDIES; HUMANS; LIVER; MALE; MIDDLE AGED; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS JAPONICA; SEVERITY OF ILLNESS INDEX; SPLEEN; YOUNG ADULT;

EID: 77955289939     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000685     Document Type: Article

References (49)

1. Leenstra T, Coutinho HM, Acosta LP, Langdon GC, Su L, et al. (2006) Schistosoma japonicum reinfection after praziquantel treatment causes anemia associated with inflammation. Infect Immun 74: 6398-6407.
2. King CH, Dickman K, Tisch DJ (2005) Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet 365: 1561-1569.
3. Ross AG, Sleigh AC, Li Y, Davis GM, Williams GM, et al. (2001) Schistosomiasis in the People's Republic of China: prospects and challenges for the 21st century. Clin Microbiol Rev 14: 270-295.
4. Friedman JF, Kanzaria HK, Acosta LP, Langdon GC, Manalo DL, et al. (2005) Relationship between Schistosoma japonicum and nutritional status among children and young adults in Leyte, the Philippines. Am J Trop Med Hyg 72: 527-533.
5. Dessein A, Kouriba B, Eboumbou C, Dessein H, Argiro L, et al. (2004) Interleukin-13 in the skin and interferon-gamma in the liver are key players in immune protection in human schistosomiasis. Immunol Rev 201: 180-190.
6. Olaso E, Friedman SL (1998) Molecular regulation of hepatic fibrogenesis. J Hepatol 29: 836-847.
7. Burke ML, Jones MK, Gobert GN, Li YS, Ellis MK, et al. (2009) Immunopathogenesis of human schistosomiasis. Parasite Immunol 31: 163-176.
8. Zhou XN, Guo JG, Wu XH, Jiang QW, Zheng J, et al. (2007) Epidemiology of schistosomiasis in the People's Republic of China, 2004. Emerg Infect Dis 13: 1470-1476.
9. Hotez PJ, Molyneux DH, Fenwick A, Kumaresan J, Sachs SE, et al. (2007) Control of neglected tropical diseases. N Engl J Med 357: 1018-1027.
10. Utzinger J, Zhou XN, Chen MG, Bergquist R (2005) Conquering schistosomiasis in China: the long march. Acta Trop 96: 69-96.
11. Webster JP, Koukounari A, Lamberton PH, Stothard JR, Fenwick A (2009) Evaluation and application of potential schistosome-associated morbidity markers within large-scale mass chemotherapy programmes. Parasitology. pp 1-11.
12. Doehring-Schwerdtfeger E, Mohamed-Ali G, Abdel-Rahim IM, Kardorff R, Franke D, et al. (1989) Sonomorphological abnormalities in Sudanese children with Schistosoma mansoni infection: a proposed staging-system for field diagnosis of periportal fibrosis. Am J Trop Med Hyg 41: 63-69.
13. Jenkins JM, Hatz C (1992) The use of diagnostic ultrasound in schistosomiasis- attempts at standardization of methodology. Cairo Working Group. Acta Trop 51: 45-63.
14. WHO (1991) Meeting on Ultrasonography in Schistosomiasis: Proposal for a Practical Guide to the Standardized use of Ultrasound in the Assessment of Pathological Changes. Cairo, Egypt.
15. Richter J, Hatz C, Campagne G, Bergquist NR, Jenkins JM (2000) Ultrasound in Schistosomiasis: A practical guide to the standard use of ultrasonography for the assessment of schistosomiasis-related morbidity. Geneva: WHO.
16. Li YS, Sleigh AC, Li Y, Tanner M, Dessein A, et al. (2002) Five-year impact of repeated praziquantel treatment on subclinical morbidity due to Schistosoma japonicum in China. Trans R Soc Trop Med Hyg 96: 438-443.
17. Li YS, Sleigh AC, Ross AG, Li Y, Williams GM, et al. (2000) Two-year impact of praziquantel treatment for Schistosoma japonicum infection in China: reinfection, subclinical disease and fibrosis marker measurements. Trans R Soc Trop Med Hyg 94: 191-197.
18. Li YS, Kardorff R, Richter J, Sun KY, Zhou H, et al. (2004) Ultrasound organometry: the importance of body height adjusted normal ranges in assessing liver and spleen parameters among Chinese subjects with Schistosoma japonicum infection. Acta Trop 92: 133-138.
19. Hsiang MS, Carlton EJ, Zhang Y, Zhong B, Qiu D, et al. (2010) Use of Ultrasonography to Evaluate Schistosoma japonicum-related Morbidity in Children, Sichuan Province, China, 2000-2007. Am J Trop Med Hyg 82: 103-111.
20. Olds GR, Olveda R, Wu G, Wiest P, McGarvey S, et al. (1996) Immunity and morbidity in schistosomiasis japonicum infection. Am J Trop Med Hyg 55: 121-126.
21. Coutinho HM, Acosta LP, Wu HW, McGarvey ST, Su L, et al. (2007) Th2 cytokines are associated with persistent hepatic fibrosis in human Schistosoma japonicum infection. J Infect Dis 195: 288-295.
22. Wiest PM, Wu G, Zhong S, McGarvey ST, Yuan J, et al. (1994) Impact of annual screening and chemotherapy with praziquantel on schistosomiasis japonica on Jishan Island, People's Republic of China. Am J Trop Med Hyg 51: 162-169.
23. Spear RC, Seto E, Liang S, Birkner M, Hubbard A, et al. (2004) Factors influencing the transmission of Schistosoma japonicum in the mountains of Sichuan Province of China. Am J Trop Med Hyg 70: 48-56.
24. Zhou YC, Guo WX (2006) Ultrasonographic Medicine, 4th Edition [in Mandarin]. Beijing: Scientific and Technical Literature Publishing House.
25. Rabe-Hesketh S, Skrondal A (2005) Multilevel and Longitudinal Modeling Using Stata. College Station, TX: Stata Press.
26. The Office of Endemic Disease Control MoH (2000) Handbook of Schistosomiasis Control. Shanghai: Shanghai Science & Technology Press.
27. Katz N, Chaves A, Pellegrino J (1972) A simple device for quantitative stool thick-smear technique in Schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo 14: 397-400.
28. Williams RL (2000) A note on robust variance estimation for cluster-correlated data. Biometrics 56: 645-646.
29. Long JS, Freese J (2006) Regression Models for Categorical Dependent Variables Using Stata, Second Edition. College Station, Texas: Stata Press.
30. Liang K, Zeger SL (1986) Longitudinal data analysis using generalized linear models. Biometrika 73: 13-22.
31. Huber PJ (1967) The behavior of maximum likelihood estimates under nonstandard conditions. Proceedings of the Fifth Berkeley Symposium on Mathematical Statistics and Probability. Berkeley, CA: University of California Press. pp 221-233.
32. White H (1980) A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity. Econometrica 48: 817-838.
33. Kleinbaum DG, Kupper LL, Morgenstern H (1982) Epidemiologic Research, Principles and quantitative methods. New York: John Wiley & Songs, Inc.
34. Wiest PM, Wu G, Zhong S, McGarvey ST, Tan E, et al. (1993) Schistosomiasis japonica on Jishan Island, Jiangxi Province, People's Republic of China: persistence of hepatic fibrosis after reduction of the prevalence of infection with age. Trans R Soc Trop Med Hyg 87: 290-294.
35. Coutinho HM, McGarvey ST, Acosta LP, Manalo DL, Langdon GC, et al. (2005) Nutritional status and serum cytokine profiles in children, adolescents, and young adults with Schistosoma japonicum-associated hepatic fibrosis, in Leyte, Philippines. J Infect Dis 192: 528-536.
36. Berhe N, Geitung JT, Medhin G, Gundersen SG (2006) Large scale evaluation of WHO's ultrasonographic staging system of schistosomal periportal fibrosis in Ethiopia. Trop Med Int Health 11: 1286-1294.
37. Carroll RJ, Ruppert D, Stefanski LA, Crainiceanu CM (2006) Measurement Error in Nonlinear Models: A Modern Perspective, Second Edition. Boca Raton: Chapman & Hall/CRC.
38. Li YS, He YK, Zeng QR, McManus DP (2003) Epidemiological and morbidity assessment of Schistosoma japonicum infection in a migrant fisherman community, the Dongting Lake region, China. Trans R Soc Trop Med Hyg 97: 177-181.
39. Ohmae H, Tanaka M, Hayashi M, Matsuzaki Y, Kurosaki Y, et al. (1992) Improvement of ultrasonographic and serologic changes in Schistosoma japonicuminfected patients after treatment with praziquantel. Am J Trop Med Hyg 46: 99-104.
40. Cai WM, Qiu DC, Hatz C (1992) Studies on ultrasonographic diagnosis of schistosomiasis japonica in China-a review of selected Chinese studies. Acta Trop 51: 37-43.
41. Berhe N, Myrvang B, Gundersen SG (2008) Reversibility of schistosomal periportal thickening/fibrosis after praziquantel therapy: a twenty-six month follow-up study in Ethiopia. Am J Trop Med Hyg 78: 228-234.
42. Martins-Leite P, Gazzinelli G, Alves-Oliveira LF, Gazzinelli A, Malaquias LC, et al. (2008) Effect of chemotherapy with praziquantel on the production of cytokines and morbidity associated with schistosomiasis mansoni. Antimicrob Agents Chemother 52: 2780-2786.
43. Chou YH, Chiou HJ, Tiu CM, Chiou SY, Lee SD, et al. (2003) Duplex Doppler ultrasound of hepatic Schistosomiasis japonica: a study of 47 patients. Am J Trop Med Hyg 68: 18-23.
44. Kresina TF, He Q, Degli Esposti S, Zern MA (1993) Hepatic fibrosis and gene expression changes induced by praziquantel treatment during immune modulation of Schistosoma japonicum infection. Parasitology 107 (Pt 4): 397-404.
45. Chigusa Y, Otake H, Ohmae H, Kirinoki M, Ilagan EJ, et al. (2006) Determination of the period for establishment of a liver network echogenic pattern in Schistosoma japonicum infection. Parasitol Int 55: 33-37.
46. Yu DB, Li Y, Sleigh AC, Yu XL, Li YS, et al. (2001) Efficacy of praziquantel against Schistosoma japonicum: field evaluation in an area with repeated chemotherapy compared with a newly identified endemic focus in Hunan, China. Trans R Soc Trop Med Hyg 95: 537-541.
47. Hatz CF (2001) The use of ultrasound in schistosomiasis. Adv Parasitol 48: 225-284.
48. King CH (2009) Toward the elimination of schistosomiasis. N Engl J Med 360: 106-109.
49. Ross AG, Sleigh AC, Li YS, Williams GM, Aligui GD, et al. (2000) Is there immunity to Schistosoma japonicum? Parasitol Today 16: 159-164.